Working for customers it could not have served a year ago: the company's deliverable capability just stepped up a class
The model's full reasoning — Q3 2018 call → NOWe need to determine if management conveys a capability step-change with all three elements: before/after, paying proof, and early stage. The transcript discusses various products: VIVITROL, ARISTADA, ALKS 5461, ALKS 3831, BIIB098, ALKS 4230. The question asks about a capability that the company can now do that it couldn't a year ago, with real customers paying for it now, and the business is still early. Look for any explicit statement about a new capability. For example, ARISTADA INITIO launch: "ARISTADA is now the first and only long-acting atypical antipsychotic in the market that can be fully dosed on day one providing patients will have the two months of coverage." That is a new product capability. But is it a capability step-change? It's a new product offering. The company can now offer a new regimen. But is that a "capability" in the sense of producing, delivering, serving? It's a product launch. The question asks about "produce, deliver, serve, handle, or perform at a scale, specification, quality, or complexity" that it couldn't before. A new product is a new capability. But does management contrast before/after? They say "now the first and only" - that's a new capability. But is there paying proof? They mention "Following the launch of ARISTADA INITIO, we have seen an acceleration in the sequential growth of the two-month dose" and "addition of both ARISTADA and ARISTADA INITIO to formularies at more than 30 hospitals during the quarter." So customers are paying for it. And is it early? They say "We expect that ARISTADA INITIO coverage will continue to expand" and "we are positioning ARISTADA to compete against the current leader" - so it's early. But is this a "capability step-change" in the sense of the company's ability to do something? It's a new product, not necessarily a new operational capability. The question might be looking for something like a new manufacturing capability, a new sales force, a new distribution channel, etc. However, the transcript also mentions "we will further expand our field and hospital-based sales force by approximately 50 sales representatives" - that's an expansion, not a step-change. Another possibility: ALKS 4230 subcutaneous dosing? That's still in development. BIIB098 NDA submission? That's not yet. The most concrete is ARISTADA INITIO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| NGVT | Ingevity Corporation | Q4 2021 | 2022-02-25 | B |
| VNDA | Vanda Pharmaceuticals Inc. | Q4 2021 | 2022-02-23 | F |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TGLS · Q2 2023 → YESThe question is about whether management conveys a new capability that they can now do something they couldn't do a year ago, that customers are paying for now, and it's still early. YES Management explicitly contrasts the new capability against the prior limitation: extra capacity now enables them to sell stand-alone architectural glass and aluminum framing products that were previously allocated to window production due to capacity constraints. This is a clear before/after step-change in the class of work they can accept and perform. Real customers are already paying for this new output: the transcript states they have a little bit more installation in stand-alone product sales the rest of the year, and they are now very well positioned to increasingly service large homebuilders’ customers as well as demand for the stand-alone aluminum and glass products, with the absorption of new capacity and ability to offer a wider range of solutions to customers described as positive overall.
TACT · Q4 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES The transcript shows management describing a clear before/after step-change in casino and gaming printers: they could produce printers before, but now they have added a third line in Q3 and begun manufacturing on a fourth line in Q4, enabling them to meet demand and take market share that the prior competitor could not supply 12 months ago.
ZVIA · Q1 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES Management describes the launch of single-serve 12-ounce cans as a first-time capability: “we began selling Zevia’s soda in single cans for the first time in a 12-ounce sleek format,” now “available cold in several grocery retailers” with “some of which is shipping now.